Incidental Malignancies Identified During Staging for Prostate Cancer With 68Ga Prostate-specific Membrane Antigen HBED-CC Positron Emission Tomography Imaging - 14/11/18
Doi : 10.1016/j.urology.2017.03.018
Andre Joshi a, b, * 
, Cheryl Nicholson b, c, Handoo Rhee b, c, Sonja Gustafson d, Kenneth Miles d, e, Ian Vela b, c
, Cheryl Nicholson b, c, Handoo Rhee b, c, Sonja Gustafson d, Kenneth Miles d, e, Ian Vela b, c a Department of Urology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
b Australian Prostate Cancer Research Centre—Queensland, Transitional Research Institute, Brisbane, Queensland, Australia
c Department of Urology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
d Department of Radiology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
e Institute of Nuclear Medicine, University College London, London, United Kingdom
*Address correspondence to: Andre Joshi, M.B.B.S., Department of Urology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.Department of UrologyPrincess Alexandra HospitalBrisbaneQueenslandAustralia
Abstract |
The rapid uptake of 68Ga prostate-specific membrane antigen HBED-CC positron emission tomography (PSMA PET) imaging for prostate cancer staging has led to concerns regarding its specificity, with uptake in both malignant and nonmalignant tissues. We describe 3 separate malignancies identified on PSMA PET imaging. The misnomer “prostate-specific membrane antigen” is demonstrated by this case and highlights the importance of continued investigation of the potential role of PSMA PET in other malignancies.
Le texte complet de cet article est disponible en PDF.| Financial Disclosure: The authors declare that they have no relevant financial interests. |
|
| Ethics and Consent: This publication was approved ethically and consent was obtained via Section 284 of the Public Health Act 2005 (Australia) in accordance with national guidelines—HREC/16/QPAH/172–SSA/16/QPAH/172 RD006398. |
© 2017
Elsevier Inc. Tous droits réservés.
Vol 104
P. e3-e4 - juin 2017 Retour au numéro
Article précédent
- Biliary Stent Migration: A Rare Cause of a Bladder Stone
- Neha R. Malhotra, Carlos Amir Esparza Monzavi, Jean-Sebastien Trepanier, Johan Nordenstam, Michael R. Abern
- Re: Zacho et al.: Unexplained Bone Pain Is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: A Prospective Study (Urology 2017;99:148-154)
- Reza Pakzad, Saeid Safiri
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?